VANGUARD GROUP INC

Holdings History for Lucid Diagnostics Inc. - Common Stock, par value $0.001 per share (LUCD)

Symbol: LUCD on Nasdaq
Investment type: Equity / Common Stock, par value $0.001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$5,415,782	4,968,608	+444,611	+9.8%	$1.09	Q4 2025
30 Sep 2025	0%	+0%	$4,569,237	4,523,997	+396,719	+9.6%	$1.01	Q3 2025
30 Jun 2025	0%	+0%	$4,746,370	4,127,278	+3,238,404	+364%	$1.15	Q2 2025
31 Mar 2025	0%	+0%	$1,324,422	888,874	+327,959		$1.49	Q1 2025
31 Dec 2024	0%	0%	$459,389	560,915	0		$0.82	Q4 2024
30 Sep 2024	0%	0%	$457,146	560,915	0		$0.82	Q3 2024
30 Jun 2024	0%	0%	$459,950	560,915	0		$0.82	Q2 2024
31 Mar 2024	0%	+0%	$454,285	560,915	+228,524	+69%	$0.81	Q1 2024
31 Dec 2023	0%	0%	$468,671	332,391	+6,825	+2.1%	$1.41	Q4 2023
30 Sep 2023	0%	0%	$380,912	325,566	+5,733	+1.8%	$1.17	Q3 2023
30 Jun 2023	0%	0%	$444,568	319,833	+400	+0.13%	$1.39	Q2 2023
31 Mar 2023	0%	0%	$447,206	319,433	0		$1.40	Q1 2023
31 Dec 2022	0%	0%	$434,429	319,433	+67	+0.02%	$1.36	Q4 2022
30 Sep 2022	0%	+0%	$489,000	319,366	+32,305	+11%	$1.53	Q3 2022
30 Jun 2022	0%	-0%	$649,000	287,061	-25,815	-8.3%	$2.26	Q2 2022
31 Mar 2022	0%	+0%	$1,051,000	312,876	+63,687	+26%	$3.36	Q1 2022
31 Dec 2021	0%	+0%	$1,338,000	249,189	+249,189	NEW	$5.37	Q4 2021

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.